doi:10.1016/j.virs.2022.01.032

[1]
Jianhui Nie, Juan Zhao, Qingqing Chen, Weijin Huang, Youchun Wang, 2014: Three amino acid residues in the envelope of human immunodeficiency virus type 1 CRF07_BC regulate viral neutralization susceptibility to the human monoclonal neutralizing antibody IgG1b12, Virologica Sinica, 29, 299-307. doi: 10.1007/s12250-014-3485-z
[2]
Jaemoo Kim, Jihyun Yang, Young Bong Kim, Hee-Jung Lee, Sehyun Kim, Haryoung Poo, 2019: Development of a Specific CHIKV-E2 Monoclonal Antibody for Chikungunya Diagnosis, Virologica Sinica, 34, 563-571. doi: 10.1007/s12250-019-00135-y
[3]
Chunpeng Yang, Rui Gong, Natalia de Val, 2019: Development of Neutralizing Antibodies against Zika Virus Based on Its Envelope Protein Structure, Virologica Sinica, 34, 168-174. doi: 10.1007/s12250-019-00093-5
[4]
Junming Shi, Zhengyuan Su, Zhaojun Fan, Jun Wang, Siqing Liu, Bo Zhang, Hongping Wei, Shoukat Jehan, Nadia Jamil, Shu Shen, Fei Deng, 2017: Extensive evolution analysis of the global chikungunya virus strains revealed the origination of CHIKV epidemics in Pakistan in 2016, Virologica Sinica, 32, 520-532. doi: 10.1007/s12250-017-4077-5
[5]
Lihong He, Wenqiang Sun, Limin Yang, Wenjun Liu, Jing Li, 2022: A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice, Virologica Sinica, 37, 746-757. doi: 10.1016/j.virs.2022.07.003
[6]
Wenxi An, Ningning Ge, Yilin Cao, Jin Sun, Xia Jin, 2017: Recent progress on chikungunya virus research, Virologica Sinica, 32, 441-453. doi: 10.1007/s12250-017-4072-x
[7]
Xin MA, Cai-jun SUN, Feng LI, Ling CHEN, 2007: HIV Vaccine-Challenges and Opportunities, Virologica Sinica, 22, 486-492.
[8]
Ting Tu, Jianbo Zhan, Danlei Mou, Wei Li, Bin Su, Tong Zhang, Tao Li, Ning Li, Hao Wu, Cong Jin, Huabiao Chen, 2017: In vitro inhibition of HIV-1 replication in autologous CD4⁺ T cells indicates viral containment by multifactorial mechanisms, Virologica Sinica, 32, 485-494. doi: 10.1007/s12250-017-3992-9
[9]
Dan Luo, Yuanjiu Miao, Xianliang Ke, Zhongyuan Tan, Chun Hu, Penghui Li, Ting Wang, Yuan Zhang, Jianhong Sun, Yan Liu, Hanzhong Wang, Zhenhua Zheng, 2020: Baculovirus Surface Display of Zika Virus Envelope Protein Protects against Virus Challenge in Mouse Model, Virologica Sinica, 35, 637-650. doi: 10.1007/s12250-020-00238-x
[10]
李红霞, 孟小林*, 徐进平, 王健, 鲁伟, 曹旭, 2004: Expression of Recombinant Envelope Proteins VP19 and VP28 of WSSV and Preparation of Neutralizing Antibody, Virologica Sinica, 19, 587-590.
[11]
Changhua Yi, Yongxiang Yi, Junwei Li, 2020: mRNA Vaccines: Possible Tools to Combat SARS-CoV-2, Virologica Sinica, 35, 259-262. doi: 10.1007/s12250-020-00243-0
[12]
Si-Qing Liu, Xiao Li, Ya-Nan Zhang, Ai-Li Gao, Cheng-Lin Deng, Jun-Hua Li, Shoukat Jehan, Nadia Jamil, Fei Deng, Hongping Wei, Bo Zhang, 2017: Detection, isolation, and characterization of chikungunya viruses associated with the Pakistan outbreak of 2016–2017, Virologica Sinica, 32, 511-519. doi: 10.1007/s12250-017-4059-7
[13]
Xue-ling WU, Chun-tao ZHANG, Xiao-ke ZHU, You-chun WANG, 2010: Detection of HPV Types and Neutralizing Antibodies in Women with Genital Warts in Tianjin City, China, Virologica Sinica, 25, 8-17. doi: 10.1007/s12250-010-3078-4
[14]
Dezhi Li, Jie Liu, Li Zhang, Tianshu Xu, Junheng Chen, Liping Wang, Qi Zhao, 2015: N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies, Virologica Sinica, 30, 449-456. doi: 10.1007/s12250-015-3664-6
[15]
Na Li, Zhen Wang, Rui Wang, Zhe-Rui Zhang, Ya-Nan Zhang, Cheng-Lin Deng, Bo Zhang, Lu-Qing Shang, Han-Qing Ye, 2021: In Vitro Inhibition of Alphaviruses by Lycorine, Virologica Sinica, 36, 1465-1474. doi: 10.1007/s12250-021-00438-z
[16]
Yingshuo Ma, Man Li, Lyu Xie, Na Gao, Dongying Fan, Kaihao Feng, Yao Yao, Yong Zhou, Ziyang Sheng, Hongning Zhou, Hui Chen, Jing An, 2021: Seroepidemiologic Study on Convalescent Sera from Dengue Fever Patients in Jinghong, Yunnan, Virologica Sinica.
[17]
Jiang-Fan Li, Lei He, Yong-Qiang Deng, Shu-Hui Qi, Yue-Hong Chen, Xiao-Lu Zhang, Shi-Xiong Hu, Rui-Wen Fan, Guang-Yu Zhao, Cheng-Feng Qin, 2021: Generation and Characterization of a Nanobody Against SARS-CoV, Virologica Sinica, 36, 1484-1491. doi: 10.1007/s12250-021-00436-1
[18]
Zhichao Yin, Yuanyuan Wu, Rui Zhu, Longfa Xu, Yu Lin, Hongwei Yang, Wenkun Fu, Qiongzi Huang, Dongqing Zhang, Jue Wang, Wei Wang, Yingbin Wang, Tong Cheng, Ningshao Xia, 2021: Development of A Neonatal Mouse Model for Coxsackievirus B1 Antiviral Evaluation, Virologica Sinica, 36, 1575-1584. doi: 10.1007/s12250-021-00444-1
[19]
Peng-cheng Yu, Akira Noguchi, Satoshi Inoue, Qing Tang, Simon Rayner, Guo-dong Liang, 2012: Comparison of RFFIT Tests with Different Standard Sera and Testing Procedures^*, Virologica Sinica, 27, 187-193. doi: 10.1007/s12250-012-3247-8
[20]
Weiyi Yu, Xianying Chen, Qiubing Chen, Peixuan Chen, Naizhang Liu, Yingjian Li, Xue Tan, Qiuhan Zhang, Yan Rao, Ming Guo, Zhixiang Huang, Xin Wang, Zhen Zhang, Wenjie Xiang, Yuzhen Zhang, Qianyun Liu, Hao Yin, Li Zhou, Yu Chen, Ke Lan, 2025: A safe and broad-spectrum SARS-CoV-2 mRNA vaccine with a new delivery system for in-situ expression, Virologica Sinica, 40, 793-803. doi: 10.1016/j.virs.2025.09.001